Leaderboards/Diabetes Management and Research

Diabetes Management and Research

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Diego Balboa
University of Helsinki
2
Julia Ware
University of Cambridge
3
Eslam Montaser
Indiana University – Purdue University Indianapolis
4
Adam Ramzy
University of British Columbia
5
Margaretha M. Visser
KU Leuven
6
Jolien De Meulemeester
KU Leuven
7
Mette Kruse Klausen
Frederiksberg Hospital
8
Olivia J. Collyns
Canterbury District Health Board
9
Jody Davis
The Ohio State University
10
Anika Bilal
Translational Research Institute for Metabolism and Diabetes

Papers

1
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study
Diabetologia|2024
55 cit.
2
Publication in The Journal of Clinical Endocrinology & Metabolism (2024) [33 citations, W4399271233]
The Journal of Clinical Endocrinology & Metabolism|2024
33 cit.
3
Publication in Diabetes Technology & Therapeutics (2024) [33 citations, W4405510172]
Diabetes Technology & Therapeutics|2024
33 cit.
4
Publication in Journal of Diabetes Science and Technology (2024) [29 citations, W4403841629]
Journal of Diabetes Science and Technology|2024
29 cit.
5
One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort study
Diabetologia|2025
19 cit.
6
Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial
Diabetes Care|2024
12 cit.
7
Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial)
BMJ Open|2025
10 cit.
8
Real-World Glycemic and Person-Reported Outcomes After Tandem Control-IQ Initiation in Children With Type 1 Diabetes
The Journal of Clinical Endocrinology & Metabolism|2025
9 cit.
9
Publication in The Journal of Clinical Endocrinology & Metabolism (2025) [7 citations, W4409076509]
The Journal of Clinical Endocrinology & Metabolism|2025
7 cit.
10
Best practices in collecting and reporting continuous glucose monitoring data in research settings
Nature Metabolism|2024
6 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Bing-Hong Zhang
Union Hospital
2
Peng Zhang
Shaoxing People's Hospital
3
Katharina Schütt
RWTH Aachen University
4
Suvi Karuranga
International Diabetes Federation
5
Gregory P. Forlenza
Diabetes Australia
6
Pamela Katz
Rush University Medical Center
7
Jeffrey R. Millman
Washington University in St. Louis
8
Ekaterina А. Shestakova
Endocrinology Research Center
9
John W. Lum
Jaeb Center for Health Research
10
Shannon Krohe
UPMC Health System

Papers

1
Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 10th edition
Diabetes Mellitus|2022
203 cit.
2
Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes
JAMA|2023
164 cit.
3
Single-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification
Nature Cell Biology|2023
86 cit.
4
Real-World Evidence of Omnipod <sup>®</sup> 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes
Diabetes Technology & Therapeutics|2024
68 cit.
5
Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric <scp>MiniMed</scp> ™ <scp>670G</scp> system trial
Pediatric Diabetes|2022
65 cit.
6
Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations
Diabetes Technology & Therapeutics|2022
65 cit.
7
Differential Function and Maturation of Human Stem Cell-Derived Islets After Transplantation
Stem Cells Translational Medicine|2022
49 cit.
8
Identification of unique cell type responses in pancreatic islets to stress
Nature Communications|2024
40 cit.
9
Comparative and integrative single cell analysis reveals new insights into the transcriptional immaturity of stem cell-derived β cells
BMC Genomics|2024
31 cit.
10
The ‘10 commandments’ for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
European Heart Journal|2024
24 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Kelly L. Close
Close Concerns (United States)
2
Claudio Cobelli
University of Padua
3
Michael Gnant
Austrian Breast & Colorectal Cancer Study Group
4
Bernard Zinman
Mount Sinai Hospital
5
William V. Tamborlane
Yale University
6
John B. Buse
Unknown
7
Roman Hovorka
Wellcome/MRC Institute of Metabolic Science
8
Lori M. Laffel
Joslin Diabetes Center
9
Guillermo E. Umpierrez
Emory University
10
Brian M. Frier
The Queen's Medical Research Institute

Papers

1
International Diabetes Federation 2017
Journal of Diabetes|2018
13.6k cit.
2
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
New England Journal of Medicine|2015
12k cit.
3
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
The Lancet|1994
8.5k cit.
4
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
The Lancet|1998
8.4k cit.
5
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
New England Journal of Medicine|2016
7.3k cit.
6
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
Diabetes Care|2008
3.8k cit.
7
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
New England Journal of Medicine|2016
3.6k cit.
8
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Diabetes Care|2018
3.5k cit.
9
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
PubMed|1998
2.2k cit.
10
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
The Journal of Clinical Endocrinology & Metabolism|2002
2.1k cit.

Reagents for Diabetes Management and Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Phospho-S6 Ribosomal Protein (Ser240/244) Antibody

Cited in 7 papers
#2215$366
View Evidence →
Abcam

Insulin antibody

Cited in 5 papers
#ab7842
View Evidence →
Cell Signaling TechnologyEvidence 67

WSTF Antibody

Cited in 5 papers
#2152$317
View Evidence →

🌟 All-Time

Most validated

Sigma-Aldrich

Monoclonal Anti-Glucagon antibody produced in mouse

Cited in 12 papers
#G2654
View Evidence →
Cell Signaling TechnologyEvidence 66

MO25 alpha/CAB39 (C49D8) Rabbit Monoclonal Antibody

Cited in 9 papers
#2716$158,348
View Evidence →
Cell Signaling TechnologyEvidence 65

Phospho-Stat3 (Tyr705) Antibody

Cited in 8 papers
#9131$362,852
View Evidence →